Sentences with phrase «clinical research consortium»

Cardiology Chief Douglas L. Mann, MD, says this clinical research consortium is one of only nine regional centers across the country investigating innovative treatments for heart failure.

Not exact matches

Senior author Dr. Leigh Hochberg — director of the BrainGate consortium and clinical trial, professor of engineering at Brown, critical care neurologist at MGH and director of the V.A. Rehabilitation Research and Development Center for Neurorestoration and Neurotechnology at the PVAMC — agreed that the new paper is a key advance.

The Clinical Research Forum, a consortium of leading academic health centers headed by Crowley, has asked pharmaceutical companies for a combined $ 10 million per year for 3 years (the minimum length of time the group expects NIH budget problems to persist), to create «bridging awards» for young investigators who have completed an NIH clinical research training grant, have narrowly missed receiving funding for an independent grant, and are employed at institutions that will match the funding and allow recipients to spend at least 75 % of their time on rClinical Research Forum, a consortium of leading academic health centers headed by Crowley, has asked pharmaceutical companies for a combined $ 10 million per year for 3 years (the minimum length of time the group expects NIH budget problems to persist), to create «bridging awards» for young investigators who have completed an NIH clinical research training grant, have narrowly missed receiving funding for an independent grant, and are employed at institutions that will match the funding and allow recipients to spend at least 75 % of their time on rResearch Forum, a consortium of leading academic health centers headed by Crowley, has asked pharmaceutical companies for a combined $ 10 million per year for 3 years (the minimum length of time the group expects NIH budget problems to persist), to create «bridging awards» for young investigators who have completed an NIH clinical research training grant, have narrowly missed receiving funding for an independent grant, and are employed at institutions that will match the funding and allow recipients to spend at least 75 % of their time on rclinical research training grant, have narrowly missed receiving funding for an independent grant, and are employed at institutions that will match the funding and allow recipients to spend at least 75 % of their time on rresearch training grant, have narrowly missed receiving funding for an independent grant, and are employed at institutions that will match the funding and allow recipients to spend at least 75 % of their time on researchresearch.

Through its effort to develop, produce and distribute a suite of genome RMs, the consortium is providing medical and research laboratories worldwide with the tools they need to advance clinical applications of whole genome sequencing, and the FDA with the ability to conduct science - based regulatory oversight of the technology.

The Program for Neuropsychiatric Research (PNPR) at McLean Hospital, founded in 2004 by Dr. Bruce Cohen, is a consortium of investigators and clinicians using laboratory, brain imaging, and clinical techniques to increase understanding of the causes of psychotic, mood, and related psychiatric disorders and use that knowledge to guide the development of improved treatments.

The Rutgers Cancer Institute of New Jersey is a matrix style, basic, clinical and population research center as well as a consortium cancer center with Princeton University, leveraging the science of the state's cancer researchers through collaboration.

This research was supported by the NIH (R01 AR062368, R01 AR062920 to A.J.G and R01 DK055679, R01 DK059888, DK055679, DK059888, and DK089763 to A.N.), and J.R.S. is supported by the Intestinal Stem Cell Consortium (U01DK103141), a collaborative research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine Research Center between Emory University, Georgia Tech and the University of research was supported by the NIH (R01 AR062368, R01 AR062920 to A.J.G and R01 DK055679, R01 DK059888, DK055679, DK059888, and DK089763 to A.N.), and J.R.S. is supported by the Intestinal Stem Cell Consortium (U01DK103141), a collaborative research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine Research Center between Emory University, Georgia Tech and the University of research project funded by the National Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID), and by the NIAID Novel, Alternative Model Systems for Enteric Diseases (NAMSED) consortium (U19AI116482), PHS Grant UL1TR000454 from the Clinical and Translational Science Award Program, and a seed grant from the Regenerative Engineering and Medicine Research Center between Emory University, Georgia Tech and the University of Research Center between Emory University, Georgia Tech and the University of Georgia.

«The consortium facilitates clinical cancer research,» he said.

The DECIPHER consortium provides these data in good faith as a research tool, but without verifying the accuracy, clinical validity or utility of the data.

The AgedBrainSYSBIO consortium is coordinated by the French National Institute for health and medical research (Inserm, Prof. Michel Simonneau) and brings together an scientists with internationally recognized expertise in systems biology of the synapse and four small to medium size enterprises (SMEs) with a leading role in the project to assure the innovation potential and translation of project results to clinical application.

She is a PI in both the Electronic Medical Records and Genomics (eMERGE) and clinical sequencing exploratory research (CSER) consortia.

As director of the pediatric motor disorders research program at the University of Utah School of Medicine in Salt Lake City, she led the Project Cure SMA Investigators Network, a trial consortium that recently published the results of two placebo - controlled trials of the HDAC - blocking agent valproic acid, neither of which demonstrated much clinical advantage from the drug1, 2.

The Kimmel Cancer Center also participates in other cancer clinical trials consortia, including those for prostate, breast, and bone marrow cancers, immunotherapy, and the Hoosier Cancer Research Network.

The Clinical and Translational Science Award (CTSA) program, part of the NIH's National Center for Advancing Translational Sciences (NCATS), supports a national consortium of more than 60 medical research institutions in 31 states.

NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world - leading consortium that can develop stem cell based therapies for Parkinson's disease and Huntington's disease toward clinical application... Read more»

The Delaney Collaboratory to Cure HIV - 1 Infection by Combination Immunotherapy (BEAT - HIV Collaboratory) is a consortium of more than 30 top HIV researchers from leading academic research institutions working with government, nonprofit organizations, and industry partners to test combinations of several novel immunotherapies under new preclinical research and clinical trials.